BioSpace News Archive

The MDiT Forum and Regulation Summit, which is widely regarded by registration, quality, compliance, medical, and R&D departments as well as project/enterprise heads, will be held as scheduled during Medtec China 2019, from September 25 to 27, 2019 in Shanghai.

Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Genomic Health, Inc. breached their fiduciary duties in connection with the proposed sale of the Company to Exact Sciences Corp..

Path to Better Health Study reveals opportunity to balance digital health with social connection

Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results for the quarter ended June 30, 2019 under International Financial Reporting Standards (IFRS).

After declining at a compound annual rate of 3.9% in the period from 2014 to 2016, the medical publishing market recovered to grow 0.5% in 2017 and 1.1% in 2018 driven by the continued growth in online delivery of book collections, journal site licenses, open access fees, databases, tools and other forms of online content—this according to Global Medical Publishing 2019-2023, the latest report from Simba Information.

Bristol-Myers Squibb Company (NYSE: BMY) today announced that the European Commission (EC) has granted unconditional approval of Bristol-Myers Squibb’s pending acquisition of Celgene Corporation (NASDAQ:CELG).

Oligonucleotides up to 300 Bases with Exceptionally Low Error Rate

Alpha-synuclein, when aggregated in the brain, is a pathological hallmark of Parkinsonian conditions and is considered an important biologic target for treating these neurodegenerative diseases.

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator, Aramchol, an oral therapy for the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis, announced today that it will host a conference call and webcast on Monday, August 5, 2019

Battelle has won an Associated Contractor Agreement for a new Defense Advanced Research Projects Agency Epigenetic Characterization and Observation program.